Pharmaceutical composition for preventing or treating cancer
AssigneeMedicinal Bioconvergence Research Center
InventorsSunghoon Kim, Nam Hoon Kwon, Dae Gyu Kim
Life of this patent
Estimating the term…
Abstract
Exemplary embodiments relate to a novel anticancer composition including a compound represented by chemical formula 1 or pharmaceutically acceptable salt thereof as an active ingredient:
Claims16
A pharmaceutical composition, comprising a compound represented by Chemical Formula 1 or a pharmaceutically acceptable salt thereof as an active ingredient in an effective amount to treat a subject in need of lung cancer treatment, and
- wherein Chemical Formula 1 is as follows:
A method for treating lung cancer, the method comprising administrating an effective amount of a compound represented by Chemical Formula 1 or a pharmaceutically acceptable salt thereof to a subject in need of lung cancer treatment, wherein Chemical Formula 1 is as follows:
A pharmaceutical formulation, comprising:
- a compound represented by Chemical Formula 1 or a pharmaceutically acceptable salt thereof as an active ingredient in an effective amount to treat a subject in need of lung cancer treatment, and
- wherein Chemical Formula 1 is as follows:
- wherein the pharmaceutical formulation is in the form of at least one of a liquid, a powder, a tablet, a capsule, a pill, or granules.
Dependencies are inferred from the claim text.